BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19969358)

  • 21. Lymphomatoid Papulosis (LyP) Associated with Diffuse Large B-cell Lymphoma and Cutaneous Anaplastic Large Cell Lymphoma: LyP as a Haematological Malignancy-related Dermadrome.
    Miyagawa F; Iioka H; Asada H
    Acta Derm Venereol; 2018 Aug; 98(8):799-800. PubMed ID: 29796688
    [No Abstract]   [Full Text] [Related]  

  • 22. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
    Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
    J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
    Ferrara G; Ena L; Cota C; Cerroni L
    Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
    Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
    Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.
    Xerri L; Adélaïde J; Avenin M; Guille A; Taix S; Bonnet N; Carbuccia N; Garnier S; Mescam L; Murati A; Chaffanet M; Coso D; Bouabdallah R; Bertucci F; Birnbaum D
    Histopathology; 2019 Mar; 74(4):654-662. PubMed ID: 30393995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary cutaneous CD30+ lymphoproliferative disorders].
    Calzado-Villarreal L; Polo-Rodríguez I; Ortiz-Romero PL
    Actas Dermosifiliogr; 2010 Mar; 101(2):119-28. PubMed ID: 20223154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical Management of CD30⁺ Lymphoproliferative Disorders.
    Hughey LC
    Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature.
    McCarty MJ; Vukelja SJ; Sausville EA; Perry JJ; James WD; Jaffe ES; Weiss RB
    Cancer; 1994 Dec; 74(11):3051-8. PubMed ID: 7954268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of T-cell lymphoid proliferations of the skin: putting all the pieces together.
    Torres-Cabala CA
    Mod Pathol; 2020 Jan; 33(Suppl 1):83-95. PubMed ID: 31664155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
    Montes-Moreno S
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
    Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK
    Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous anaplastic large cell lymphoma.
    Brown RA; Fernandez-Pol S; Kim J
    J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
    Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
    J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous anaplastic large cell lymphoma of the medial canthus and orbit.
    Koreen IV; Cho RI; Frueh BR; Elner VM
    Ophthalmic Plast Reconstr Surg; 2009; 25(1):63-5. PubMed ID: 19273934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of lymphomatoid papulosis type E in a young adult: An uncommon entity.
    Rajashekara Swamy M; Pollock S; J Goldberg L; Shen L
    J Cutan Pathol; 2021 May; 48(5):694-700. PubMed ID: 33533041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki-1-positive anaplastic large-cell lymphoma of the eyelid.
    Tanzi E; Edelman M; Rosenbaum PS
    Arch Ophthalmol; 1999 Jul; 117(7):955-8. PubMed ID: 10408463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.